FDA Inspection
Roche Molecular Systems, Inc.Roche Molecular Systems, Inc. – FDA Inspection, Jul 19, 2017
Record Details
This FDA Inspection record concerns Roche Molecular Systems, Inc., with an inspection on July 19, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Guang Gao (Issuing Officer)
- Prabhu P. Raju (FDA Associated Person)
- Simone E. Pitts (FDA Associated Person)
View Company Profile
ID · 61eafec8-5360-49e5-a7c3-050777797698
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1020421
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Roche Molecular Systems, Inc.
14| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 8, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 31, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 24, 2017 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| July 13, 2016 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Roche Molecular Systems, Inc.
- FDA Inspection 1323692 - 2026-06-12
- FDA Inspection 1224711 - 2023-12-08
- FDA Inspection 1100926 - 2019-07-31
- FDA Inspection 1027092 - 2017-07-24
- FDA Inspection 979955 - 2016-07-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.